TAIM
OGN icon

TD Ameritrade Investment Management’s Organon & Co OGN Stock Holding History

TD Ameritrade Investment Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1
Closed – – 640
2021
Q4 		$0 Buy
+1
New +$33 ﹤0.01% 680
2021
Q3 		– Sell
-59
Closed -$2K – 684
2021
Q2 		$2K Buy
+59
New +$1.94K ﹤0.01% 601

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

TD Ameritrade Investment Management's OGN Position: Q1 2022 in Review

TD Ameritrade Investment Management sold out of Organon & Co (OGN) in Q1 2022, closing a stake of 1 share.

TD Ameritrade Investment Management first reported a position in OGN in Q2 2021 and held it in 2 quarters. The position peaked at $2K in Q2 2021. 818 funds tracked by Wall St. Rank hold OGN as of Q1 2022.

  • TD Ameritrade Investment Management reported no remaining Organon & Co position as of Q1 2022 after selling out during the quarter.
  • TD Ameritrade Investment Management sold 1 Organon & Co share in Q1 2022.
  • TD Ameritrade Investment Management first reported a position in Organon & Co in Q2 2021 and held it in 2 quarters.
  • TD Ameritrade Investment Management's Organon & Co position peaked at $2K in Q2 2021.
  • 818 funds tracked by Wall St. Rank held Organon & Co as of Q1 2022.

Based on TD Ameritrade Investment Management's 13F filing for Q1 2022, filed 16 May 2022.